<DOC>
	<DOCNO>NCT01652885</DOCNO>
	<brief_summary>The purpose study investigate safety , tolerability , systemic exposure AN2728 Topical Ointment , 2 % , subject atopic dermatitis .</brief_summary>
	<brief_title>Safety , Tolerability , PK AN2728 Adolescents With Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Male female 12 17 year age , inclusive Clinical diagnosis atopic dermatitis ( accord criterion Hanifin Rajka ) AD treatable area ( excludes scalp venous access area ) involve ≥10 % ≤35 % total body surface area ( BSA ) Investigator 's Static Global Assessment ( ISGA ) score 2 3 Normal clinically significant screen laboratory result Have adequate venous access permit repeat PK sample Days 1 9 uninfected skin treat study drug ; untreated venous access area provide margin least 5 cm radius around venipuncture site Willing able comply study instruction commit attend visit Females must use highly effective method birth control . Parent/guardian ability understand , agree sign study Informed Consent Form ( ICF ) prior initiation protocolrelated procedure ; subject ability give assent Significant confounding condition assess study doctor Unstable actively infect AD Active potentially recurrent dermatologic condition atopic dermatitis may confound evaluation History evidence allergy require acute chronic treatment ( except seasonal allergic rhinitis ) Concurrent recent use certain topical systemic medication phototherapy without sufficient washout period Treatment type cancer ( except squamous cell carcinoma , basal cell carcinoma , carcinoma situ skin , curatively treated cryosurgery surgical excision ) within last 5 year Current pregnancy lactation , intent become pregnant study Known sensitivity component study drug Participated trial investigational drug device within 30 day participation research study concurrent study Participated previous AN2728 clinical study</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>atopic dermatitis</keyword>
</DOC>